These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23681089)

  • 1. Pseudoarthrosis in atypical femoral fracture: case report.
    Giannotti S; Bottai V; Dell'Osso G; De Paola G; Ghilardi M; Guido G
    Osteoporos Int; 2013 Nov; 24(11):2893-5. PubMed ID: 23681089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral atypical femoral fractures after long-term alendronate therapy: a case report.
    Bamrungsong T; Pongchaiyakul C
    J Med Assoc Thai; 2010 May; 93(5):620-4. PubMed ID: 20524451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management.
    Koh A; Guerado E; Giannoudis PV
    Bone Joint J; 2017 Mar; 99-B(3):295-302. PubMed ID: 28249967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.
    Lee JK
    Int J Rheum Dis; 2009 Jul; 12(2):149-54. PubMed ID: 20374333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case reports: two femoral insufficiency fractures after long-term alendronate therapy.
    Sayed-Noor AS; Sjödén GO
    Clin Orthop Relat Res; 2009 Jul; 467(7):1921-6. PubMed ID: 19198962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
    Cross MB; Nam D; van der Meulen MC; Bostrom MP
    J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.
    Puah KL; Tan MH
    Acta Orthop; 2011 Jun; 82(3):380-2. PubMed ID: 21561306
    [No Abstract]   [Full Text] [Related]  

  • 8. Femoral canal obliteration secondary to prolonged alendronate use: a case report.
    Lim CT; Setiobudi T; Das De S
    J Orthop Surg (Hong Kong); 2012 Apr; 20(1):115-7. PubMed ID: 22535826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of femoral fracture nonunion after long-term bisphosphonate use.
    Grady MK; Watson JT; Cannada LK
    Orthopedics; 2012 Jun; 35(6):e991-5. PubMed ID: 22691683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alendronate-associated femoral insufficiency fractures and femoral stress reactions.
    Wang K; Moaveni A; Dowrick A; Liew S
    J Orthop Surg (Hong Kong); 2011 Apr; 19(1):89-92. PubMed ID: 21519086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
    Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH
    Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rational approach to management of alendronate-related subtrochanteric fractures.
    Das De S; Setiobudi T; Shen L; Das De S
    J Bone Joint Surg Br; 2010 May; 92(5):679-86. PubMed ID: 20436006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report.
    Niikura T; Lee SY; Sakai Y; Kuroda R; Kurosaka M
    J Med Case Rep; 2015 May; 9():103. PubMed ID: 25943378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical fractures on long term bisphosphonates therapy.
    Hussein W; Cunningham C; Logan H; Fallon C; Murphy S
    Ir Med J; 2011; 104(10):308, 310. PubMed ID: 22256444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
    Park KT; Lee KB
    Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bone-end intervention on fracture healing in bisphosphonate-related atypical femoral fractures.
    Canbek U; Akgun U; Aydogan NH
    Orthop Traumatol Surg Res; 2020 Feb; 106(1):77-83. PubMed ID: 31784413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical femoral fracture after long-term alendronate treatment: report of a case evidenced with magnetic resonance imaging.
    Kao CM; Huang PJ; Chen CH; Chen SJ; Cheng YM
    Kaohsiung J Med Sci; 2012 Oct; 28(10):555-8. PubMed ID: 23089322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Bögl HP; Aspenberg P; Schilcher J
    Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral low-energy sequential femoral shaft fractures in patients on long-term bisphosphonate therapy.
    Çakmak S; Mahiroğulları M; Keklikçi K; Sarı E; Erdik B; Rodop O
    Acta Orthop Traumatol Turc; 2013; 47(3):162-72. PubMed ID: 23748615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implant failure caused by non-union of bisphosphonate-associated subtrochanteric femur fracture.
    O'Neill BJ; O'hEireamhoin S; Morrissey DI; Keogh P
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24700046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.